NO20042500L - Chemokin-reseptorantagonister og metoder for anvendelse derav - Google Patents
Chemokin-reseptorantagonister og metoder for anvendelse deravInfo
- Publication number
- NO20042500L NO20042500L NO20042500A NO20042500A NO20042500L NO 20042500 L NO20042500 L NO 20042500L NO 20042500 A NO20042500 A NO 20042500A NO 20042500 A NO20042500 A NO 20042500A NO 20042500 L NO20042500 L NO 20042500L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- receptor antagonists
- chemokine receptor
- chemokine
- antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/52—Oxygen atoms attached in position 4 having an aryl radical as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Rheumatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- AIDS & HIV (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/989,086 US20020169155A1 (en) | 1998-09-04 | 2001-11-21 | Chemokine receptor anagonists and methods of use therefor |
PCT/US2002/036953 WO2003045942A2 (en) | 1998-09-04 | 2002-11-13 | Chemokine receptor antagonists and methods of use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20042500L true NO20042500L (no) | 2004-06-15 |
NO328166B1 NO328166B1 (no) | 2009-12-21 |
Family
ID=32713949
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20042500A NO328166B1 (no) | 2001-11-21 | 2004-06-15 | Chemokin-reseptorantagonister, farmasoytiske preparater inneholdende slike, slike forbindelser for anvendelse i terapi samt anvendelse av slike forbindelser for fremstilling av medikament for behandling av sykdom |
Country Status (24)
Country | Link |
---|---|
EP (3) | EP2286811B1 (no) |
JP (5) | JP4889920B2 (no) |
KR (3) | KR100919346B1 (no) |
CN (3) | CN104031054A (no) |
AR (2) | AR037394A1 (no) |
AT (1) | ATE320431T1 (no) |
AU (1) | AU2002352772B2 (no) |
BR (1) | BR0213633A (no) |
CA (1) | CA2467672C (no) |
CY (1) | CY1107243T1 (no) |
DE (2) | DE60209937D1 (no) |
DK (1) | DK1448566T5 (no) |
ES (2) | ES2396186T3 (no) |
HK (2) | HK1063789A1 (no) |
IL (3) | IL161669A0 (no) |
MY (2) | MY146601A (no) |
NO (1) | NO328166B1 (no) |
NZ (3) | NZ596484A (no) |
PL (2) | PL217918B1 (no) |
PT (1) | PT1448566E (no) |
SG (2) | SG195393A1 (no) |
SI (1) | SI1448566T1 (no) |
TW (1) | TWI308568B (no) |
ZA (1) | ZA200403530B (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4889920B2 (ja) * | 2001-11-21 | 2012-03-07 | ミレニアム ファーマシューティカルズ, インコーポレイテッド | ケモカイン受容体アンタゴニストおよびその使用方法 |
US7541365B2 (en) | 2001-11-21 | 2009-06-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
TWI291467B (en) * | 2002-11-13 | 2007-12-21 | Millennium Pharm Inc | CCR1 antagonists and methods of use therefor |
EP2404901B1 (en) * | 2007-12-03 | 2013-05-22 | Novartis AG | 1,2-Disubstituted 4-benzylamino-pyrrolidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |
TWI431010B (zh) * | 2007-12-19 | 2014-03-21 | Lilly Co Eli | 礦皮質素受體拮抗劑及使用方法 |
CN104292142B (zh) * | 2013-07-17 | 2019-05-14 | 天津大地康和医药技术有限公司 | 一种n-芳基杂环丁烷脱芳基方法 |
CN105237455A (zh) * | 2015-10-14 | 2016-01-13 | 湖南华腾制药有限公司 | 一种3-取代氮杂环丁烷的制备方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD80449A (no) * | ||||
JPS5250634B2 (no) | 1971-08-23 | 1977-12-26 | ||
JPS61152673A (ja) | 1984-12-26 | 1986-07-11 | Kyowa Hakko Kogyo Co Ltd | ジベンズ〔b,e〕オキセピン誘導体の製造法 |
US5089496A (en) | 1986-10-31 | 1992-02-18 | Schering Corporation | Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies |
CA1341044C (en) | 1988-04-28 | 2000-07-04 | Frank J. Villani | Benzopyrido piperidine, piperidylidene and peperazine compounds, compositions, methods of manufacture and methods of use |
JPH06508129A (ja) | 1991-05-23 | 1994-09-14 | シェリング・コーポレーション | 新規のベンゾピリドピペリジリデン化合物、組成物、製造法および使用法 |
AU2392392A (en) | 1991-07-23 | 1993-02-23 | Schering Corporation | Novel benzopyrido piperylidene compounds, compositions, methods of manufacture and methods of use |
JP3664176B2 (ja) | 1992-11-10 | 2005-06-22 | ジェネンテック・インコーポレーテッド | C−c ckr−1,c−cケモカインレセプター |
AU5270796A (en) * | 1995-04-07 | 1996-10-23 | Novo Nordisk A/S | N-substituted azaheterocyclic carboxylic acids and esters th ereof |
WO1997022338A1 (en) * | 1995-12-15 | 1997-06-26 | Novo Nordisk A/S | Novel method |
WO1999037651A1 (en) * | 1998-01-21 | 1999-07-29 | Millenium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
US6509346B2 (en) * | 1998-01-21 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
AU2331199A (en) * | 1998-09-04 | 2000-03-27 | Kyowa Hakko Kogyo Co. Ltd. | Chemokine receptor antagonists and methods of use therefor |
WO2001009137A1 (en) * | 1999-07-28 | 2001-02-08 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
DE60026556T2 (de) | 1999-10-20 | 2006-12-14 | Kingspan Holdings (Irl) Ltd., Kingscourt | Zellulärer kunststoff auf basis phenolharz |
TW503427B (en) | 2000-07-25 | 2002-09-21 | Koninkl Philips Electronics Nv | Display tube comprising a mask with vibration damping means |
JP4889920B2 (ja) * | 2001-11-21 | 2012-03-07 | ミレニアム ファーマシューティカルズ, インコーポレイテッド | ケモカイン受容体アンタゴニストおよびその使用方法 |
DE102011084910A1 (de) | 2011-10-20 | 2013-04-25 | Wobben Properties Gmbh | Verfahren und Vorrichtung zum Einspeisen elektrischen Stroms in ein elektrisches Netz |
-
2002
- 2002-11-13 JP JP2003547392A patent/JP4889920B2/ja not_active Expired - Fee Related
- 2002-11-13 EP EP10012138A patent/EP2286811B1/en not_active Expired - Lifetime
- 2002-11-13 CA CA2467672A patent/CA2467672C/en not_active Expired - Fee Related
- 2002-11-13 EP EP02789725A patent/EP1448566B3/en not_active Expired - Lifetime
- 2002-11-13 SI SI200230327T patent/SI1448566T1/sl unknown
- 2002-11-13 NZ NZ596484A patent/NZ596484A/xx not_active IP Right Cessation
- 2002-11-13 EP EP06004401.3A patent/EP1688418B1/en not_active Expired - Lifetime
- 2002-11-13 NZ NZ585746A patent/NZ585746A/en not_active IP Right Cessation
- 2002-11-13 AT AT02789725T patent/ATE320431T1/de active
- 2002-11-13 PL PL369599A patent/PL217918B1/pl unknown
- 2002-11-13 AU AU2002352772A patent/AU2002352772B2/en not_active Ceased
- 2002-11-13 DE DE60209937A patent/DE60209937D1/de not_active Expired - Lifetime
- 2002-11-13 CN CN201410171050.6A patent/CN104031054A/zh active Pending
- 2002-11-13 IL IL16166902A patent/IL161669A0/xx unknown
- 2002-11-13 CN CNA2006101054502A patent/CN1911930A/zh active Pending
- 2002-11-13 KR KR1020047007728A patent/KR100919346B1/ko not_active IP Right Cessation
- 2002-11-13 ES ES10012138T patent/ES2396186T3/es not_active Expired - Lifetime
- 2002-11-13 KR KR1020077024914A patent/KR100952767B1/ko not_active IP Right Cessation
- 2002-11-13 SG SG2011011095A patent/SG195393A1/en unknown
- 2002-11-13 DK DK02789725T patent/DK1448566T5/da active
- 2002-11-13 BR BR0213633-3A patent/BR0213633A/pt not_active Application Discontinuation
- 2002-11-13 ES ES02789725T patent/ES2260497T7/es active Active
- 2002-11-13 SG SG200603354-2A patent/SG165152A1/en unknown
- 2002-11-13 DE DE60209937T patent/DE60209937T4/de not_active Expired - Lifetime
- 2002-11-13 PL PL403800A patent/PL403800A1/pl unknown
- 2002-11-13 CN CN02827426.1A patent/CN1585772B/zh not_active Expired - Fee Related
- 2002-11-13 KR KR1020107000732A patent/KR101001092B1/ko not_active IP Right Cessation
- 2002-11-13 NZ NZ532827A patent/NZ532827A/en not_active IP Right Cessation
- 2002-11-13 PT PT02789725T patent/PT1448566E/pt unknown
- 2002-11-14 TW TW091133354A patent/TWI308568B/zh not_active IP Right Cessation
- 2002-11-14 MY MYPI20064630A patent/MY146601A/en unknown
- 2002-11-14 AR ARP020104390A patent/AR037394A1/es active IP Right Grant
- 2002-11-14 MY MYPI20024277A patent/MY142646A/en unknown
-
2004
- 2004-04-29 IL IL161669A patent/IL161669A/en not_active IP Right Cessation
- 2004-05-10 ZA ZA200403530A patent/ZA200403530B/xx unknown
- 2004-06-15 NO NO20042500A patent/NO328166B1/no not_active IP Right Cessation
- 2004-09-02 HK HK04106595A patent/HK1063789A1/xx not_active IP Right Cessation
-
2006
- 2006-06-05 CY CY20061100740T patent/CY1107243T1/el unknown
-
2007
- 2007-02-06 IL IL181191A patent/IL181191A/en not_active IP Right Cessation
-
2010
- 2010-05-06 JP JP2010106678A patent/JP2010229136A/ja active Pending
-
2011
- 2011-08-19 HK HK11108768.0A patent/HK1154504A1/xx not_active IP Right Cessation
-
2013
- 2013-04-24 AR ARP130101374A patent/AR090829A2/es unknown
- 2013-05-13 JP JP2013101580A patent/JP5878494B2/ja not_active Expired - Fee Related
-
2014
- 2014-12-02 JP JP2014244379A patent/JP5936669B2/ja not_active Expired - Fee Related
-
2016
- 2016-03-01 JP JP2016039332A patent/JP2016138122A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS7040A (is) | 5-HT viðtakabindlar og notkun þeirra | |
IS8190A (is) | Ný P2X7 viðtakamótlyf og notkun þeirra | |
IS7329A (is) | Flúr setinn sýklóalkanóindól og notkun þeirra semprostaglandín D2 viðtaka mótlyfja | |
DK1446379T3 (da) | Arylanilin-beta2-adrenergiske receptoragonister | |
IS7801A (is) | Púrín efnasambönd og notkun þeirra sem kannabinóíð viðtaka bindla | |
DK1417175T3 (da) | Substituerede dihydro-3-halo-1h-pyrazol-5-carboxylater og fremstillingog anvendelse heraf | |
NO20040072L (no) | Nye substituerte benzimidazol-doseringsformer og fremgangsmate for anvendelse av samme | |
DK2662390T3 (da) | Interferon alpha receptor 1-antistoffer og anvendelse heraf | |
NO20013809D0 (no) | Indolderivater og anvendelse derav som MCP-1 antagonister | |
PT1379504E (pt) | Derivados bipiperidinilo e sua utilização como inibidores de receptores de quimioquinas | |
IS8526A (is) | CRF viðtakamótlyf og aðferðir tengdar þeim | |
NO20030471D0 (no) | Karboksamidforbindelser og deres anvendelse som antagonister for en 11CBY-reseptor | |
NO20041008L (no) | Karbazolderivater og anvendelse derav som NPY5 reseptor antagonister | |
HK1154504A1 (en) | Chemokine receptor antagonists and methods of use thereof | |
NO20025762D0 (no) | Bicykliske cykloheksylaminer og anvendelse derav som NMDA- reseptorantagonister | |
NO20026103L (no) | 1-amino-alkylcycloheksaner som 5-HT3 og neuronale nikotinreseptorantagonister | |
NO20031997D0 (no) | CRF-reseptor-antagonist og metoder relatert dertil | |
NO20043799L (no) | 2-oksasolaminer og deres anvendelse som 5-HT2B reseptor antagonister | |
DE60222015D1 (de) | Ccr-3-rezeptorantagonisten vii | |
IS6818A (is) | Histamín viðtaka mótlyf | |
AU2003300396A8 (en) | Chemokine antagonists and uses thereof | |
ATE320254T1 (de) | Crf receptor antagonisten | |
NO20035319D0 (no) | En G-proteinkoblet reseptor og anvendelse derav | |
SE0003996D0 (sv) | Receptorantagonister | |
GB0124346D0 (en) | Receptor and its use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |